Liqiong Luo

495 total citations
9 papers, 396 citations indexed

About

Liqiong Luo is a scholar working on Molecular Biology, Immunology and Surgery. According to data from OpenAlex, Liqiong Luo has authored 9 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Immunology and 2 papers in Surgery. Recurrent topics in Liqiong Luo's work include Congenital heart defects research (2 papers), MicroRNA in disease regulation (2 papers) and Pregnancy and preeclampsia studies (1 paper). Liqiong Luo is often cited by papers focused on Congenital heart defects research (2 papers), MicroRNA in disease regulation (2 papers) and Pregnancy and preeclampsia studies (1 paper). Liqiong Luo collaborates with scholars based in China and New Zealand. Liqiong Luo's co-authors include Zuo‐Hua Feng, Dong Li, Lei Zhang, Zhihui Liang, Chuanwang Song, Bo Li, Bo Huang, Guanghui Liu, Guimei Zhang and Xuesong Dong and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Journal of Hepatology.

In The Last Decade

Liqiong Luo

8 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liqiong Luo China 6 221 120 110 73 39 9 396
Nina Sopel Germany 9 211 1.0× 91 0.8× 98 0.9× 85 1.2× 58 1.5× 14 383
Shigeru Ashino Japan 13 254 1.1× 72 0.6× 140 1.3× 75 1.0× 62 1.6× 20 466
Anna‐Karin Ekman Sweden 12 363 1.6× 244 2.0× 98 0.9× 59 0.8× 30 0.8× 16 541
Samia Akthar United Kingdom 8 224 1.0× 72 0.6× 182 1.7× 33 0.5× 95 2.4× 9 442
Jonathan Hacha Belgium 8 134 0.6× 96 0.8× 186 1.7× 53 0.7× 113 2.9× 8 417
Shinichi Takenaka Japan 8 192 0.9× 113 0.9× 90 0.8× 26 0.4× 94 2.4× 12 343
Serena M. Lugli Switzerland 8 275 1.2× 55 0.5× 90 0.8× 94 1.3× 26 0.7× 9 393
Henning Weigt Germany 7 118 0.5× 221 1.8× 60 0.5× 33 0.5× 24 0.6× 10 434
M Kagami Japan 9 171 0.8× 84 0.7× 221 2.0× 34 0.5× 32 0.8× 28 382
Christine Delprat France 10 215 1.0× 171 1.4× 160 1.5× 107 1.5× 24 0.6× 13 467

Countries citing papers authored by Liqiong Luo

Since Specialization
Citations

This map shows the geographic impact of Liqiong Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liqiong Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liqiong Luo more than expected).

Fields of papers citing papers by Liqiong Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liqiong Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liqiong Luo. The network helps show where Liqiong Luo may publish in the future.

Co-authorship network of co-authors of Liqiong Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Liqiong Luo. A scholar is included among the top collaborators of Liqiong Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liqiong Luo. Liqiong Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Gao, Kexin, et al.. (2024). GATA4: Regulation of expression and functions in goat granulosa cells. Domestic Animal Endocrinology. 89. 106859–106859. 1 indexed citations
2.
Li, Xi, Jing Zhou, Wei Yuan, et al.. (2024). TBC1D20 is Essential for Postnatal Uterine Development and Endometrial Decidualization in Mice. SHILAP Revista de lepidopterología. 51(6).
3.
Sun, Bo, et al.. (2023). MiR-135b-5p targets ADAM12 to suppress invasion and accelerate trophoblast apoptosis in preeclampsia. Placenta. 143. 69–79. 5 indexed citations
4.
Luo, Liqiong, et al.. (2021). The Effect and Mechanism of lncRNA NR2F1-As1/miR-493-5p/MAP3K2 Axis in the Progression of Gastric Cancer. Journal of Oncology. 2021. 1–10. 13 indexed citations
5.
Wu, Fenghua, Liqiong Luo, Yi Liu, et al.. (2014). Cyclin D1b splice variant promotes αvβ3-mediated adhesion and invasive migration of breast cancer cells. Cancer Letters. 355(1). 159–167. 26 indexed citations
6.
Song, Chuanwang, Liqiong Luo, Lei Zhang, et al.. (2008). IL-17-Producing Alveolar Macrophages Mediate Allergic Lung Inflammation Related to Asthma. The Journal of Immunology. 181(9). 6117–6124. 245 indexed citations
7.
Ma, Lixin, Liqiong Luo, Haiquan Qiao, et al.. (2006). Complete eradication of hepatocellular carcinomas by combined vasostatin gene therapy and B7H3-mediated immunotherapy. Journal of Hepatology. 46(1). 98–106. 56 indexed citations
8.
Mei, Wenjie, Yun‐Jun Liu, Na Wang, et al.. (2006). The photocleavage properties of a novel ruthenium(II) complex on liver cancer cells Bel-7402 DNA. Transition Metal Chemistry. 31(8). 1024–1027. 3 indexed citations
9.
Luo, Liqiong, Haiquan Qiao, Fanqiang Meng, et al.. (2005). Arsenic trioxide synergizes with B7H3‐mediated immunotherapy to eradicate hepatocellular carcinomas. International Journal of Cancer. 118(7). 1823–1830. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026